Liposome Drug Products: Chemistry, Manufacturing, and Controls; Human Pharmacokinetics and Bioavailability; and Labeling Documentation
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
April 5, 2018
October 4, 2021
b27b2c8a-0cb8-4775-aba0-e2a39c06fd48
Related Documents
Quality Attribute Considerations for Chewable Tablets Guidance for Industry
Guidance DocumentAugust 21, 2018Center for Drug Evaluation and Research
Environmental Assessment: Questions and Answers Regarding Drugs With Estrogenic, Androgenic, or Thyroid Activity
Guidance DocumentMarch 4, 2016Center for Drug Evaluation and Research
Regulatory Classification of Pharmaceutical Co-Crystals
Guidance DocumentFebruary 15, 2018Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox